New drug trial offers hope for ovarian cancer that stopped responding to standard chemo
NCT ID NCT06315491
Summary
This study is testing an experimental drug called CBX-12 for women whose ovarian cancer has stopped responding to platinum-based chemotherapy. It aims to see if the drug is safe and can shrink tumors. About 40 participants will receive one of two different doses every three weeks to find the most effective amount.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY OVARIAN CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Albert Einstein College of Medicine Montefiore Medical
ACTIVE_NOT_RECRUITINGNew York, New York, 10021, United States
-
Allegheny Singer Research Institute D/B/A Ahn Research Institution
RECRUITINGPittsburgh, Pennsylvania, 15212, United States
Contact Phone: •••-•••-••••
-
Arizona Oncology Associates
ACTIVE_NOT_RECRUITINGTucson, Arizona, 85711, United States
-
D&H Cancer Research Center
ACTIVE_NOT_RECRUITINGMargate, Florida, 33063, United States
-
Honor Health
WITHDRAWNScottsdale, Arizona, 85260, United States
-
Mary Crowley Cancer Research
RECRUITINGDallas, Texas, 75251, United States
Contact Phone: •••-•••-••••
-
Multicare Institute For Research & Innovation
ACTIVE_NOT_RECRUITINGTacoma, Washington, 98405, United States
-
Northwest Cancer Centers
WITHDRAWNDyer, Indiana, 46311, United States
-
Norton Cancer Institute
ACTIVE_NOT_RECRUITINGLouisville, Kentucky, 40202, United States
-
Oncology Associates of Oregon
ACTIVE_NOT_RECRUITINGEugene, Oregon, 97401, United States
-
Pci Nyu Langone Health
ACTIVE_NOT_RECRUITINGNew York, New York, 10016, United States
-
South Florida Gynecology
ACTIVE_NOT_RECRUITINGTampa, Florida, 33606, United States
-
Texas Oncology- Gulf Coast
ACTIVE_NOT_RECRUITINGThe Woodlands, Texas, 77380, United States
-
University Hospitals Seidman Cancer Center
ACTIVE_NOT_RECRUITINGCleveland, Ohio, 44106, United States
-
Usc Norris Comprehensive Cancer Center
ACTIVE_NOT_RECRUITINGLos Angeles, California, 90033, United States
-
Women's Cancer Care
ACTIVE_NOT_RECRUITINGCovington, Louisiana, 70433, United States
-
Yale University School of Medicine
ACTIVE_NOT_RECRUITINGNew Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.